Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.

Journal of clinical psychopharmacology - 1 Feb 2008

Lane Hsien-Yuan, Liu Yi-Ching, Huang Chieh-Liang, Chang Yue-Cune, Wu Po-Lun, Huang Chiung-Hsien, Tsai Guochuan E

Abstract excerpt

OBJECTIVE: Polymorphisms of the gene encoding the regulator of G-protein signaling subtype 4 (RGS4) are associated with schizophrenia. This study aims to investigate the association of 4 RGS4 polymorphisms (single nucleotide polymorphisms [SNPs] 1, 4, 7, and 18), implicated in previous studies, with baseline symptoms and treatment response to risperidone in patients with schizophrenia. METHODS: One hundred twenty...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Psychiatric Status Rating Scales

Share to RGS Proteins

Share to Risperidone

Share to Schizophrenia

Share to Schizophrenic Psychology

Share to Social Behavior

Source

Identifiers

PMID: 18204343
DOI: 10.1097/jcp.0b013e3181603f5a

Genes

RGS4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.PMID 18204343Read ↗

An association study of RGS4 polymorphisms with clinical phenotypes of schizophrenia in a Chinese population.Semantic proximity Read ↗

Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.Semantic proximity Read ↗

Association of RGS2 and RGS5 variants with schizophrenia symptom severity.Semantic proximity Read ↗

Support for RGS4 as a susceptibility gene for schizophrenia.Semantic proximity Read ↗

Association between RGS4 gene polymorphisms and schizophrenia: A protocol for systematic review and meta-analysis.Semantic proximity Read ↗

RGS4 polymorphisms and risk of schizophrenia: an association study in Han Chinese plus meta-analysis.Semantic proximity Read ↗

Association between RGS4 variants and psychotic-like experiences in nonclinical individuals.Semantic proximity Read ↗

Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population levelSemantic proximity Read ↗

Can RGS4 polymorphisms be viewed as credible risk factors for schizophrenia? A critical review of the evidence.Semantic proximity Read ↗

Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.Semantic proximity Read ↗

Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia.Semantic proximity Read ↗

Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.